Friday, July 10, 2026

Drug profile · INN

brilliant blue g

brilliant blue g (TISSUEBLUE) is a membrane staining aid in ophthalmic surgery. Route of administration: ophthalmic. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — brilliant blue g
US status
approved
Class
Route
OPHTHALMIC
Patents
0
Programs
4
Data quality
0.84

Quick answer

brilliant blue g (TISSUEBLUE) is a membrane staining aid in ophthalmic surgery. Route of administration: ophthalmic. Current US regulatory status: approved.

Key facts

INN brilliant blue g
Brand TISSUEBLUE
Mechanism Membrane staining aid in ophthalmic surgery
Route OPHTHALMIC
Formulation SOLUTION

Mechanism of action

Membrane staining aid in ophthalmic surgery

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Tissue Plasminogen Activator Phase 3 · Chinese University of · Pleural Infection
  2. Tissue Plasminogen Activator (Alteplase) Phase 3 · Neuroscience Trials Australia · Stroke
  3. Tissue Plasminogen Activator (Alteplase) Phase 3 · Chinese Academy of · Stroke
  4. Tissue Plasminogen Activator (tPA) Phase 1 · Hospital Authority · Peritoneal Dialysis

Frequently asked questions

What is brilliant blue g?

brilliant blue g (TISSUEBLUE) is a membrane staining aid in ophthalmic surgery. Route of administration: ophthalmic. Current US regulatory status: approved.

What is the brand name for brilliant blue g?

TISSUEBLUE is a marketed brand name for brilliant blue g. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of brilliant blue g?

brilliant blue g has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.